Long-term outcomes and clinical impact of anti-HLA donor-specific antibodies (DSA) after liver transplantation: prospective study in a pilot cohort. | Zendy

A. Marcos | Zendy; Raquel Díaz Ruiz | Zendy; Mario Romero Cristóbal | Zendy; Ainhoa Fernández Yunquera | Zendy; Fernando DíazFontenla | Zendy; L Pérez Carazo | Zendy; María Isabel Peligros Gómez | Zendy; Jose Luis Vicario Moreno | Zendy; Magdalena Salcedo | Zendy; Rafael Bañares | Zendy

Open Access

Long-term outcomes and clinical impact of anti-HLA donor-specific antibodies (DSA) after liver transplantation: prospective study in a pilot cohort.

Author(s) -

A. Marcos,

Raquel Díaz Ruiz,

Mario Romero Cristóbal,

Ainhoa Fernández Yunquera,

Fernando DíazFontenla,

L Pérez Carazo,

María Isabel Peligros Gómez,

Jose Luis Vicario Moreno,

Magdalena Salcedo,

Rafael Bañares

Publication year - 2020

Publication title -

revista española de enfermedades digestivas

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.331

H-Index - 38

eISSN - 2340-4167

pISSN - 1130-0108

DOI - 10.17235/reed.2020.7337/2020

Subject(s) - medicine , liver transplantation , human leukocyte antigen , prospective cohort study , cohort , donor specific antibodies , antibody , term (time) , transplantation , cohort study , immunology , antigen , physics , quantum mechanics

he presence of donor-specific antibodies (DSA) is thought to affect survival of the allograft and patient after liver transplantation (LT). However, their significance is not well understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research